A detailed history of Watts Gwilliam & Co., LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Watts Gwilliam & Co., LLC holds 7,853 shares of ABT stock, worth $919,821. This represents 0.2% of its overall portfolio holdings.

Number of Shares
7,853
Previous 7,785 0.87%
Holding current value
$919,821
Previous $810 Million 11.18%
% of portfolio
0.2%
Previous 0.25%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$100.07 - $118.13 $6,804 - $8,032
68 Added 0.87%
7,853 $900 Million
Q1 2024

May 15, 2024

BUY
$109.52 - $120.96 $852,613 - $941,673
7,785 New
7,785 $810 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Watts Gwilliam & Co., LLC Portfolio

Follow Watts Gwilliam & Co., LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Watts Gwilliam & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Watts Gwilliam & Co., LLC with notifications on news.